Alisertib in Treating Patients With Relapsed or Refractory Peripheral T-Cell Non-Hodgkin Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
161 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Bcca-Vancouver Cancer Centre
Vancouver, British Columbia, Canada
- Providence Hospital
Mobile, Alabama, United States
- the University of Arizona Cancer Center-North Campus
Tucson, Arizona, United States
- the University of Arizona Cancer Center-Orange Grove Campus
Tucson, Arizona, United States
- the University of Arizona Medical Center-University Campus
Tucson, Arizona, United States
- Alta Bates Summit Medical Center-Herrick Campus
Berkeley, California, United States
- Mills - Peninsula Hospitals
Burlingame, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Sutter Cancer Research Consortium
Novato, California, United States
- California Pacific Medical Center-Pacific Campus
San Francisco, California, United States
- Sutter Pacific Medical Foundation
Santa Rosa, California, United States
- Sutter Solano Medical Center/cancer Center
Vallejo, California, United States
- Saint Francis Hospital and Medical Center
Hartford, Connecticut, United States
- Beebe Medical Center
Lewes, Delaware, United States
- Christiana Care Health System-Christiana Hospital
Newark, Delaware, United States
- Medstar Georgetown University Hospital
Washington D.C., District of Columbia, United States
- Emory University/winship Cancer Institute
Atlanta, Georgia, United States
- Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, United States
- Kuakini Medical Center
Honolulu, Hawaii, United States
- Oncare Hawaii-Liliha
Honolulu, Hawaii, United States
- Oncare Hawaii Inc-Kuakini
Honolulu, Hawaii, United States
- Oncare Hawaii Inc-Pob Ii
Honolulu, Hawaii, United States
- Queen'S Medical Center
Honolulu, Hawaii, United States
- Straub Clinic and Hospital
Honolulu, Hawaii, United States
- University of Hawaii Cancer Center
Honolulu, Hawaii, United States
- Castle Medical Center
Kailua, Hawaii, United States
- Wilcox Memorial Hospital and Kauai Medical Clinic
Lihue, Hawaii, United States
- Oncare Hawaii Inc-Pali Momi
‘Aiea, Hawaii, United States
- Pali Momi Medical Center
‘Aiea, Hawaii, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- Hematology and Oncology Associates
Chicago, Illinois, United States
- Northwestern University
Chicago, Illinois, United States
- Hematology Oncology Associates of Illinois-Highland Park
Highland Park, Illinois, United States
- Presence Saint Mary'S Hospital
Kankakee, Illinois, United States
- North Shore Hematology Oncology
Libertyville, Illinois, United States
- Loyola University Medical Center
Maywood, Illinois, United States
- Illinois Cancer Specialists-Niles
Niles, Illinois, United States
- Hematology Oncology Associates of Illinois - Skokie
Skokie, Illinois, United States
- Mcfarland Clinic Pc-William R Bliss Cancer Center
Ames, Iowa, United States
- Ottumwa Regional Health Center
Ottumwa, Iowa, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2011
- Primary completion
- 31 Dec 2014
- Completion
- 31 Mar 2015
- Last update posted
- 10 Mar 2016
- Registered enrollment
- 42
- Registry id
- NCT01466881
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.